natgillin/translations-raw huggingface dataset:
ABILIFY with food, drink and alcohol 
Zdravilo ABILIFY skupaj s hrano, pijačo in alkoholom
Do not push the tablet through the foil because this could damage the tablet. 
Tablete ne potiskajte skozi folijo, ker lahko tableto tako poškodujete.
Dose adjustments due to interactions 
Prilagajanje odmerka zaradi medsebojnega delovanja
Less than 1 % of unchanged aripiprazole was excreted in the urine and approximately 18 % was recovered unchanged in the faeces. 
Manj kot 1 % aripiprazola se je nespremenjenega izločilo v urinu in približno 18 % ga je bilo mogoče nespremenjenega najti v blatu.
Also contains: lactose monohydrate. 
Vsebuje tudi: laktoza monohidrat.
Blood pressure-lowering medicines: ABILIFY may increase the effect of medicines used to lower the blood pressure. 
Zdravila za zniževanje krvnega tlaka: zdravilo ABILIFY lahko okrepi učinek zdravil, ki se uporabljajo za zniževanje krvnega tlaka.
Try to take ABILIFY at the same time each day. 
Prizadevajte si vzeti zdravilo ABILIFY vsak dan ob istem času.
• unusual movements (especially of the face or tongue) and reduced level of consciousness. 
• nenavadne gibe (posebno v mišicah obraza ali jezika) in zmanjšano stopnjo zavesti.
This should be considered in cases where full alertness is required, e.g., when driving a car or handling machines. 
To je treba upoštevati, ko je potrebna popolna zbranost, npr. pri vožnji avtomobila ali upravljanja strojev.
Pathological gambling and other impulse control disorders 
Patološko hazardiranje in druge motnje nadzora impulzov
If you miss a dose, take the missed dose as soon as you remember but do not take two doses in one day. 
Če ste pozabili vzeti odmerek, ga vzemite takoj, ko se spomnite, vendar ne vzemite dveh odmerkov na en dan.
This medicine can be taken regardless of meals. 
To zdravilo lahko jemljete ne glede na obroke.
This medicine will be given to you under medical supervision; it is therefore unlikely that you will be given too much. 
To zdravilo se daje pod zdravniškim nadzorom, zato verjetnost, da bi dobili prekomerni odmerek, ni velika.
Due to insufficient safety information in humans and concerns raised by animal reproductive studies, this medicinal product should not be used in pregnancy unless the expected benefit clearly justifies the potential risk to the foetus. 
Zaradi nezadostnih podatkov o varnosti pri človeku in zaradi pomislekov, ki jih porajajo študije vpliva na sposobnost razmnoževanja pri živalih, se tega zdravila pri nosečnicah ne sme uporabljati, razen če pričakovana korist nedvomno prevlada nad možnim tveganjem za plod.
Alternatively, disperse the tablet in water and drink the resulting suspension. 
Druga možnost je, da tableto raztopi v vodi in popije nastalo suspenzijo.
Blood pressure, pulse, respiratory rate and level of consciousness should be monitored regularly. 
Redno je treba nadzirati krvni tlak, pulz, frekvenco dihanja in stopnjo zavesti.
Fructose may damage teeth. 
Fruktoza lahko poškoduje zobe.
Even if you feel better, do not alter or discontinue the daily dose of ABILIFY without first consulting your doctor. 
Tudi če se počutite bolje, ne spreminjajte dnevnega odmerka in ne nehajte jemati zdravila ABILIFY, ne da bi se prej posvetovali z zdravnikom.
If you have the impression that the effect of ABILIFY is too strong or too weak, talk to your doctor or pharmacist. 
Če menite, da je učinek zdravila ABILIFY premočan ali prešibak, se posvetujte z zdravnikom ali farmacevtom.
Care must be taken to avoid inadvertent injection of this medicinal product into a blood vessel. 
Potrebna je previdnost, da ne pride do nenamernega injiciranja tega zdravila v krvno žilo.
Therefore cardiovascular monitoring should be started immediately and should include continuous electrocardiographic monitoring to detect possible arrhythmias. 
Zato je treba takoj uvesti kardiovaskularni nadzor, ki mora vključevati stalno elektrokardiografsko spremljanje za odkritje morebitnih motenj srčnega ritma.
The correct amount of solution will be injected into your muscle by your doctor or nurse. 
Ustrezen odmerek raztopine za injiciranje vam bo v mišico injiciral zdravnik ali medicinska sestra.
Do not open the blister until ready to administer. 
Pretisnega omota ne odprite, dokler niste pripravljeni, da zdravilo zaužijete.
The highest nontumorigenic exposure in female rats was 7 times the human exposure at the recommended dose. 
Največja netumorogena izpostavljenost samic podgan je bila 7-krat večja od izpostavljenosti človeka pri priporočenem odmerku.
It is important not to miss your dose. 
Pomembno je, da ne izpustite načrtovanega odmerka.
Use within 6 months after first opening. 
Porabite v 6 mesecih po prvem odprtju.
• high blood sugar, 
• visok krvni sladkor,
If you cannot reach your doctor, go to the nearest hospital and take the pack with you. 
pojdite v najbližjo bolnišnico in škatlo z zdravilom vzemite s seboj.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. 
Nosečnost, dojenje in plodnost Če ste noseči ali dojite, menite, da bi lahko bili noseči ali načrtujete zanositev, se posvetujte z zdravnikom, preden vzamete to zdravilo.
Contains aspartame and lactose. 
Vsebuje aspartam in laktozo.
• rapid heartbeat, agitation/aggressiveness, problems with speech. 
• hitro bitje srca, vznemirjenost/agresivnost, težave pri govoru,
Tell your doctor if you or your family/carer notices that you are developing urges or cravings to behave in ways that are unusual for you and you cannot resist the impulse, drive or temptation to carry out certain activities that could harm yourself or others. 
Obvestite svojega zdravnika, če vi sami ali vaša družina/skrbnik opazite, da se pri vas razvija nagib ali želja po vedenju, ki za vas ni običajno, in se ne morete upreti impulzu, težnji ali skušnjavi po dejanjih,
• involuntary loss of urine (incontinence), 
• nehotno uhajanje urina (inkontinenca),
Caution should be taken, particularly if you are an elderly patient or have some debility. 
zlasti če ste starejši ali oslabeli bolnik.
The total body clearance of aripiprazole is 0.7 mL/min/kg, which is primarily hepatic. 
Celotni telesni očistek aripiprazola je 0,7 ml/min/kg in je v prvi vrsti hepatičen.
The orodispersible tablet can be taken with or without liquid. 
Orodisperzibilno tableto lahko vzamete s tekočino ali brez nje.
• low levels of white blood cells, 
• nizke ravni belih krvnih celic,
The point estimate of the hazard ratio (HR) was 0.461 (95 % confidence interval, 0.242 to 0.879) in the full population. 
Ocenjena vrednost razmerja ogroženosti (RO) je bila 0,461 (95-% interval zaupanja, 0,242 do 0,879) pri celotni poulaciji.
• certain antibiotics used to treat tuberculosis (rifabutin, rifampicin) 
• določene antibiotike, ki se uporabljajo za zdravljenje tuberkuloze (rifabutin, rifampicin).
Following a single oral dose of [14C]-labelled aripiprazole, approximately 27 % of the administered radioactivity was recovered in the urine and approximately 60 % in the faeces. 
Po enem samem peroralnem odmerku aripiprazola, označenega s [14C], se je približno 27 % aplicirane radioaktivnosti pojavilo v urinu in približno 60 % v blatu.
If you miss an injection, you should contact your doctor to arrange your next injection as soon as you can. 
Če ste izpustili injiciranje, takoj pokličite zdravnika, da vas čim prej naroči na naslednji odmerek.
< 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000) and not known (cannot be estimated from the available data). 
pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000) in neznana pogostnost (ni mogoče oceniti iz razpoložljivih podatkov).
In subpopulation analyses on patients with mixed episodes or on patients with severe agitation, a similar pattern of efficacy to the overall population was observed but statistical significance could not be established due to a reduced sample size. 
V analizi bolnikov z mešanimi epizodami in bolnikov s hudo agitacijo so opazili podoben vzorec učinkovitosti, kot pri splošni populaciji, vendar statistične pomembnosti zaradi premajhnega vzorca ni bilo mogoče ugotoviti.
People with this condition may also feel depressed, guilty, anxious or tense. 
Osebe s to boleznijo so lahko tudi depresivne, imajo občutek krivde, tesnobnosti ali napetosti.
The singledose pharmacokinetics of aripiprazole was linear and dose-proportional. 
Farmakokinetika posamičnih odmerkov aripiprazola je bila linearna in sorazmerna odmerku.
Do not use this medicine in children and adolescents under 18 years of age. 
To zdravilo ni namenjeno uporabi pri otrocih in mladostnikih, mlajših od 18 let.
If you are an elderly patient suffering from dementia (loss of memory and other mental abilities), you or your carer/relative should tell your doctor if you have ever had a stroke or "mini" stroke. 
Če ste starejša oseba in imate demenco (slabšanje spomina in drugih duševnih sposobnosti), morate vi ali vaš skrbnik/sorodnik zdravniku povedati, če ste kdaj imeli možgansko kap ali „malo” kap.
In the same trials, cerebrovascular adverse reactions (e.g. stroke, transient ischaemic attack), including fatalities, were reported in patients (mean age: 84 years; range: 78 to 88 years). 
V istih preskušanjih so poročali o cerebrovaskularnih neželenih učinkih (npr. možganski kapi, prehodnem ishemičnem napadu), vključno s smrtnimi primeri (povprečna starost bolnikov: 84 let, razpon: 78 do 88 let).
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. 
Obvestite zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo, vključno z zdravili, ki ste jih dobili brez recepta.
• blood clots in the veins especially in the legs (symptoms include swelling, pain and redness in the leg), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing (if you notice any of these symptoms, seek medical advice immediately), 
• krvni strdki v venah, zlasti v venah nog (simptomi vključujejo oteklino, bolečino in rdečino noge), ki lahko potujejo po krvnih žilah v pljuča in povzročijo bolečino v prsih in težave z dihanjem (če opazite katerega od navedenih simptomov, takoj poiščite zdravniško pomoč),
Since the orodispersible tablet is fragile, it should be taken immediately on opening the blister. 
Ker je orodisperzibilna tableta krhka, jo mora bolnik vzeti takoj, ko odpre pretisni omot.
The information below is obtained from studies with oral aripiprazole. 
Spodnji podatki so pridobljeni iz študij s peroralnim aripiprazolom.
The orodispersible tablet should be placed in the mouth on the tongue, where it will rapidly disperse in saliva. 
Orodisperzibilne tablete mora bolnik položiti v usta na jezik, kjer v slini hitro razpadejo.
The following side effects have been reported since the marketing of oral aripiprazole but the frequency for them to occur is not known: 
O naslednjih neželenih učinkih so poročali v obdobju od prihoda peroralnega aripiprazola na trg; pogostnost pojavljanja le-teh pa ni znana:
Simultaneous administration of injectable antipsychotics and parenteral benzodiazepine may be associated with excessive sedation and cardiorespiratory depression. 
Sočasno dajanje antipsihotikov za injiciranje in parenteralnih benzodiazepinov je lahko povezano z močno sedacijo in kardiorespiratorno depresijo.
In adults it also prevents this condition from returning in patients who have responded to the treatment with ABILIFY. 
Zdravilo tudi preprečuje ponovitve bolezni pri odraslih bolnikih, ki so se odzvali na zdravljenje z zdravilom ABILIFY.
Orodispersible tablets or oral solution may be used as an alternative to ABILIFY tablets for patients who have difficulty swallowing ABILIFY tablets (see section 5.2). 
Orodisperzibilne tablete ali peroralna raztopina se lahko uporabijo kot alternativa tabletam ABILIFY pri bolnikih, ki tablete ABILIFY težko pogoltnejo (glejte poglavje 5.2).
Caution should be taken when treating patients at higher risk, and a lower starting dose should be considered (e.g., elderly or debilitated patients; see section 4.2). 
Pri zdravljenju bolnikov z večjim tveganjem je potrebna previdnost, zato je treba razmisliti o nižjem začetnem odmerku (npr. pri starejših ali oslabljenih bolnikih; glejte poglavje 4.2).
In clinical trials and post-marketing experience, accidental or intentional acute overdose of aripiprazole alone was identified in adult patients with reported estimated doses up to 1,260 mg with no fatalities. 
V kliničnih preskušanjih in obdobju pomarketinških izkušenj so ugotovili naključno ali namerno preveliko odmerjanje aripiprazola samega pri odraslih bolnikih z ocenjenimi odmerki do 1.260 mg brez smrtnih primerov.
• The active substance is aripiprazole. 
• Učinkovina je aripiprazol.
This medicine contains 200 mg of fructose and 400 mg of sucrose in each mL. 
To zdravilo vsebuje 200 mg fruktoze in 400 mg saharoze na mililiter.
• increased diastolic blood pressure, 
• zvišan diastolični krvni tlak,
Therefore, ABILIFY is not recommended for use in patients below 13 years of age (see sections 4.8 and 5.1). 
Uporabe zdravila ABILIFY se zato pri bolnikih, mlajših od 13 let, ne priporoča (glejte poglavji 4.8 in 5.1).
• serotonin syndrome (a reaction which may cause feelings of great happiness, drowsiness, 
• serotoninski sindrom (reakcija, ki lahko povzroči močan občutek sreče, omotico, okornost,
Urinary incontinence Urinary retention 
Bolezni sečil urinska inkontinenca retencija urina
Patients were 6 to 18 years and presented an average score of 29 on TTS-YGTSS at baseline. 
Bolniki so bili stari od 6 do 18 let, njihov povprečni izhodiščni rezultat na lestvici TTS-YGTSS pa je bil 29.
Contains fructose, sucrose, E218, and E216. 
Vsebuje fruktozo, saharozo, E 218 in E 216.
Extrapyramidal symptoms were mainly reported during the stabilisation phase in 17 % of patients, with tremor accounting for 6.5 %. 
O ekstrapiramidnih simptomih so poročali predvsem med stabilizacijsko fazo, in sicer pri 17 % bolnikov, od tega je 6,5 %
The total dose of ABILIFY (all formulations) should not exceed 30 mg per day. 
Skupni odmerek zdravila ABILIFY (vse farmacevtske oblike) ne sme preseči 30 mg na dan.
Patients can experience increased urges, particularly for gambling, and the inability to control these urges while taking aripiprazole. 
Pri bolnikih se lahko poveča impulzivnost, zlasti želja po igrah na srečo, med jemanjem aripiprazola pa teh niso več sposobni nadzorovati.
Solution for injection 1 vial 
Raztopina za injiciranje 1 viala
What ABILIFY is and what it is used for 
Kaj je zdravilo ABILIFY in za kaj ga uporabljamo
Treatment with ABILIFY solution for injection should be discontinued as soon as clinically appropriate and the use of oral aripiprazole should be initiated. 
Zdravljenje z zdravilom ABILIFY raztopina za injiciranje je treba prekiniti takoj, ko je to klinično primerno, in uvesti zdravljenje s peroralnimi oblikami aripiprazola.
To enhance absorption and minimise variability, injection into the deltoid or deep within the gluteus maximus muscle, avoiding adipose regions, is recommended. 
Zaradi hitrejše absorpcije in zmanjšanja variabilnosti priporočamo injiciranje v deltoidno mišico ali globoko v veliko glutealno mišico, pri čemer se je treba izogibati adipoznih področij.
ABILIFY is used to treat quickly symptoms of agitation and distressing behaviour that may occur in a disease characterised by symptoms such as: 
Zdravilo ABILIFY uporabljamo za hitro zdravljenje simptomov agitacije in vedenjskih sprememb, ki se lahko pojavijo pri bolezni, za katero so značilni simptomi, kot so:
However, the estimation of the HR for the younger (13 to 14 years) group was not precise, reflecting the smaller number of subjects in that group (aripiprazole, n = 29; placebo, n = 12), and the confidence interval for this estimation (ranging from 0.151 to 1.628) did not allow conclusions to be drawn on the presence of a treatment effect. 
Vendar pa ocena razmerja ogroženosti pri skupini mlajših mladostnikov (13 do 14 let) ni bila točna zaradi manjšega števila preskušancev v tej skupini (aripiprazol, n = 29; placebo, n = 12), interval zaupanja za to oceno (ki je od 0,151 do 1,628)
It is not known if it is safe and effective in these patients. 
Varnost in učinkovitost tega zdravila pri teh bolnikih nista znana.
Following any confirmed or suspected accidental overdose/inadvertent intravenous administration, close observation of the patient is needed and if any potentially medically serious sign or symptom develops, monitoring, which should include continuous electrocardiographic monitoring, is required. 
Po vsakem potrjenem ali domnevno nenamernem prevelikem odmerjanju/nenamernem intravenskem dajanju zdravila, je potreben skrben zdravniški nadzor in, če se razvijejo morebitni zdravstveno resni znaki ali simptomi, je zahtevano spremljanje, ki mora vključevati elektrokardiografsko spremljanje.
After a 13 to 26-week stabilisation on aripiprazole (2 mg/day to 15 mg/day) patients with a stable response were either maintained on aripiprazole or substituted to placebo for further 16 weeks. 
Po 13 do 26 tednih stabilizacije na aripiprazolu (2 mg/dan do 15 mg/dan) so bolniki s stabilnim odzivom nadaljnjih 16 tednov bodisi ostali na aripiprazolu ali pa so prešli na placebo.
Aripiprazole is well absorbed, with peak plasma concentrations occurring within 3 to 5 hours after dosing. 
Aripiprazol se dobro absorbira in doseže največjo koncentracijo v plazmi v 3 do 5 urah po uporabi.
In contrast the 95 % confidence interval for the HR in the older subgroup (aripiprazole, n = 69; placebo, n = 36) was 0.242 to 0.879 and hence a treatment effect could be concluded in the older patients. 
V nasprotju s tem je bil 95-% interval zapanja za RO pri starejši podskupini (aripiprazol, n = 69; placebo, n = 36) od 0,242 do 0,879, tako da je pri starejših bolnikih mogoče sprejeti zaključek o učinkovitosti zdravljenja.
Removal of the intact orodispersible tablet from the mouth is difficult. 
Orodisperzibilno tableto je iz ust težko vzeti nedotaknjeno.
In three placebo-controlled trials (n = 938; mean age: 82.4 years; range: 56 to 99 years) of aripiprazole in elderly patients with psychosis associated with Alzheimer's disease, patients treated with aripiprazole were at increased risk of death compared to placebo. 
V treh s placebom nadzorovanih preskušanjih (n = 938, povprečna starost: 82,4 leta, razpon: 56 do 99 let) aripiprazola pri starejših bolnikih s psihozo, povezano z Alzheimerjevo boleznijo, je bilo tveganje smrti večje pri bolnikih, ki so dobivali aripiprazol, kot pri tistih, ki so dobivali placebo.
Patients treated with any antipsychotics, including aripiprazole, should be observed for signs and symptoms of hyperglycaemia (such as polydipsia, polyuria, polyphagia and weakness) and patients with diabetes mellitus or with risk factors for diabetes mellitus should be monitored regularly for worsening of glucose control (see section 4.8). 
Bolnike, ki dobivajo kateri koli antipsihotik, vključno z aripiprazolom, je treba opazovati glede znakov in simptomov hiperglikemije (npr. polidipsije, poliurije, polifagije in šibkosti); bolnike z diabetesom mellitusom ali dejavniki tveganja zanj pa je treba redno nadzirati, da bi odkrili poslabšanje urejenosti glukoze (glejte poglavje 4.8).
It can be taken with or without liquid. 
Vzeti jih je mogoče s tekočino ali brez nje.
In both of these short-term trials, the clinical relevance of the efficacy findings has not been established, considering the magnitude of treatment effect compared to the large placebo effect and the unclear effects regarding psycho-social functioning. 
Klinična pomembnost rezultatov za učinkovitost v obeh kratkih preskušanjih ni bila ugotovljena, zaradi magnitude učinka zdravila v primerjavi z velikim učinkom placeba in nejasnega vpliva na psihosocialno delovanje.
Aripiprazole has minor to moderate influence on the ability to drive and use machines due to potential nervous system and visual effects, such as sedation, somnolence, syncope, vision blurred, diplopia (see section 4.8). 
Aripiprazol ima blag do zmeren vpliv na sposobnost vožnje in upravljanje s stroji zaradi morebitnega vpliva na živčni sistem in vid, kot je sedacija, somnolenca, sinkopa, zamegljen vid in diplopija (glejte poglavje 4.8).
The maximum daily dose of aripiprazole is 30 mg (including all formulations of ABILIFY). 
Največji dnevni odmerek aripiprazola je 30 mg (vključno z vsemi ostalimi farmacevtskimi oblikami zdravila ABILIFY).
Other medicines and ABILIFY 
Druga zdravila in zdravilo ABILIFY
Contents of the pack and other information What ABILIFY contains 
Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo ABILIFY
For single tablet removal, open the package and peel back the foil on the blister to expose the tablet. 
Da boste iz omota vzeli eno samo tableto, odprite pakiranje in s pretisnega omota potegnite folijo, da boste razkrili tableto.
• reports of abnormal liver tests values, 
• primeri nenormalnih izvidov laboratorijskih jetrnih preiskav,
Among the patients included in the primary efficacy analysis, 139 patients had a current co-morbid diagnosis of ADHD. 
Izmed bolnikov, ki so bili vključeni v primarno analizo učinkovitosti, je imelo 139 bolnikov sočasno tudi diagnozo motnje pomanjkanja pozornosti (ADHD - Attention deficit hyperactivity disorder).
If you realise you have taken more ABILIFY than your doctor has recommended (or if someone else has taken some of your ABILIFY), contact your doctor right away. 
Če ste vzeli večji odmerek zdravila ABILIFY, kot bi smeli Če ugotovite, da ste vzeli več zdravila ABILIFY, kot vam je priporočil zdravnik (ali če je vaše zdravilo ABILIFY vzel kdo drug), se takoj posvetujte s svojim zdravnikom.
Aripiprazole is widely distributed throughout the body with an apparent volume of distribution of 4.9 L/kg, indicating extensive extravascular distribution. 
Aripiprazol se obsežno porazdeli po telesu in ima navidezni volumen porazdelitve 4,9 l/kg, kar kaže na izdatno zunajžilno porazdelitev.
Outer carton: 
Zunanja ovojnina:
• selective-serotonin-reuptake-inhibitors (SSRIs) (such as paroxetine and fluoxetine) used for depression, OCD, panic and anxiety 
• selektivne zaviralce privzema serotonina (SSRI) (kot sta paroksetin in fluoksetin) uporabljamo za depresijo, OCD, paniko in anksioznost,
Excipients with known effect (per mL) 
Pomožna(e) snov(i) z znanim učinkom (na ml):
If parenteral benzodiazepine therapy is deemed necessary in addition to aripiprazole solution for injection, patients should be monitored for excessive sedation and for orthostatic hypotension (see section 4.5). 
Če se presodi, da je poleg aripiprazola v obliki raztopine za injiciranje potrebno tudi zdravljenje s parenteralnimi benzodiazepini, je treba bolnike nadzirati glede prekomerne sedacije in ortostatske hipotenzije (glejte poglavje 4.5).
Patients receiving ABILIFY solution for injection should be observed for orthostatic hypotension. 
Bolnike, ki prejemajo zdravila ABILIFY raztopina za injiciranje, je treba nadzirati glede ortostatske hipotenzije.
• onset or worsening of diabetes, ketoacidosis (ketones in the blood and urine) or coma, 
• pojav sladkorne bolezni (diabetesa) ali njeno poslabšanje, ketoacidoza (ketoni v krvi in urinu)
• allergic reaction (e.g. swelling in the mouth, tongue, face and throat, itching, hives), 
• alergijska reakcija (npr. oteklost ust, jezika, obraza in žrela, srbenje, izpuščaj),
ABILIFY contains the active substance aripiprazole and belongs to a group of medicines called antipsychotics. 
Zdravilo ABILIFY vsebuje učinkovino aripiprazol in spada v skupino zdravil, imenovanih antipsihotiki.
It may be harmful for people with phenylketonuria (PKU), a rare genetic disorder in which phenylalanine builds up because the body cannot remove it properly. 
Lahko škoduje ljudem, ki imajo fenilketonurijo, redko genetsko bolezen, pri kateri pride do kopičenja fenilalanina, ker se ne more ustrezno odstranjevati iz telesa.